Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Anemia, Diamond-Blackfan

• A Phase I/II, Intra-Patient Dose-Escalation Study of the Selective GlyT1 Inhibitor, Bitopertin for Steroid-Refractory Diamond-Blackfan Anemia.
• Treatment of Refractory Diamond-Blackfan Anemia With Eltrombopag
• AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
• The Use of Trifluoperazine in Transfusion Dependent DBA
• Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study
• T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
• Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation
• Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer
• Related Hematopoietic Stem Cell Transplantation (HSCT) for Genetic Diseases of Blood Cells
• L-leucine in Diamond Blackfan Anemia Patients
• Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies
• Safety Study of Gene Modified Donor T-cells Following TCR Alpha Beta Depleted Stem Cell Transplant
• Bone Marrow Transplant With Abatacept for Non-Malignant Diseases
• Human Placental-Derived Stem Cell Transplantation
• Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
• Safety and Efficacy Study of Sotatercept in Adults With Transfusion Dependent Diamond Blackfan Anemia
• Pilot Phase I/II Study of Amino Acid Leucine in Treatment of Patients With Transfusion-Dependent Diamond Blackfan Anemia
• Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation
• Pilot Lenalidomide in Adult Diamond-Blackfan Anemia Patients w/ RBC Transfusion-Dependent Anemia
• Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron Overload
• Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in Firs
• Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders
• Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
• Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload
• Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia
• Stem Cell Transplant for Bone Marrow Failure Syndromes
• Stem Cell Transplant for Hemoglobinopathy
• Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias
• Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias
• Mobilization of Stem Cells With G-CSF for Collection From Patients With Diamond-Blackfan Anemia
• A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow Failure
• Medical Treatment for Diamond Blackfan Anemia